ASSESSMENT OF THE RISK OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS WITH CARDIOVASCULAR DISEASE
Relevance: International research shows that polypharmacy is common among older people. Most older people take more than five drugs, some of which are not medically necessary. Research has clearly established a strong link between polypharmacy and negative clinical consequences. The result of polypharmacy is unwanted drug reactions, an increase in drug side effects and drug-drug interactions. To improve the pharmacotherapy of older people, it is important to use the tools for rationalizing drug treatment. One of them is Beers criteria.
Objective of the study: To optimize pharmacotherapy for patients of the older age group by identifying unwanted and potentially dangerous drugs using Beers criteria.
Materials and research methods. Retrospective analysis of medical records of inpatients of patients aged 65 years and older with cardiac profile for the period from January to December 2017.
Results of the study: As a result of the analysis of the case histories of the cardiological hospital, excessive polypharmacy was revealed - the appointment of 10 or more drugs in 43 (40.9%) patients. Of the unwanted drugs from Bierce's criteria, selective COX-2 inhibitors were used most of all - 18.1% of cases, ketorolac was prescribed least of all - 1.0%. Among the drugs that aggravate heart failure, NSAIDs and nondihydropyridine CCBs were prescribed. Medicines that are potentially dangerous for the elderly are vasodilators - 100.0% and diuretics - 93.4%, to a lesser extent - carbamazepine - 4.8% of cases. Undesirable drug combinations were noticed: warfarin + amiodarone - 1.0%, warfarin + meloxicam - 1.0%. Of the drugs to be avoided in renal failure, spironolactone was found in 1.0% of cases.
Conclusions: The results of this study indicate the need for careful monitoring of the efficacy and safety of drug therapy. It is necessary to apply various methods to combat polypharmacy and unwanted drug reactions, in particular, Beers criteria. Various trainings and master classes for training doctors will help to establish pharmacotherapy for patients.
Number of Views: 263
Category of articles:
Original articles
Bibliography link
Musapirova A.B., Tuleutaeva R.E., Makhatova A.R., Smailova Zh.K., Ukenov A.Zh., Ukenova D.B. Assessment of the risk of adverse drug reactions in elderly patients with cardiovascular disease // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 2, pp. 118-126. doi 10.34689/SH.2021.23.2.012Related publications:
VALIDATION OF THE KAZAKH VERSION OF THE DEPRESSION ANXIETY STRESS SCALE (DASS-21) IN MEDICAL FACULTY STAFF SAMPLE: THE PILOT STUDY
PREDICTIVE VALUE OF PSYCHOMETRIC TESTING IN CONTEXT OF CREATING ADAPTIVE ENVIRONMENT FOR HIGHER MEDICAL EDUCATION
ASSESSMENT OF STUDENTS' AWARENESS ABOUT THE HARMS OF MICROPLASTICS ON THE HUMAN BODY
THE IMPACT OF COMPLAINTS ON QUALITY OF LIFE, PSYCHOLOGICAL WELL-BEING AND HEALTH OF MEDICAL WORKERS
DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE FOR PATIENTS "STUDYING THE OPINION OF PATIENTS' SATISFACTION WITH NURSE INDEPENDENT APPOINTMENT AT THE LEVEL OF PRIMARY HEALTH CARE"